You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Olumiant
Olumiant (baricitinib) is an oral Janus kinase (JAK) inhibitor used primarily for the treatment of moderate to severe rheumatoid arthritis in adults. It works by inhibiting specific enzymes involved in the inflammatory process, helping to reduce inflammation and improve symptoms associated with autoimmune diseases. Olumiant is indicated for patients who have had an inadequate response to one or more disease-modifying antirheumatic drugs (DMARDs).
Oops! We currently don’t have the pricing information for this drug.
But we're continually improving our service to help you save and earn rebates on your medications. If your drug isn't listed on NiHowdy, you can still present your NiHowdy savings card at the pharmacy. We'll work to secure any eligible rebates for that drug and pass the savings back to you retroactively.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
Frequently Asked Questions
How long does it take for Olumiant to work?
Patients may begin to notice improvements in symptoms within a few weeks, but optimal results can take longer and vary among individuals.
Can I take Olumiant if I have a history of infections?
You should discuss your medical history with your healthcare provider, as previous infections may influence the safety and appropriateness of Olumiant for you.
What should I do if I miss a dose?
If you miss a dose, take it as soon as you remember. If it’s almost time for your next dose, skip the missed dose and continue your regular schedule. Do not double up.
Is it safe to use Olumiant during pregnancy?
Olumiant should be used during pregnancy only if the potential benefits justify the potential risks. Consult your healthcare provider for guidance.
What are the signs of serious side effects to watch for?
Monitor for signs of infection (fever, persistent cough), signs of blood clots (swelling, pain in the legs), or gastrointestinal issues (severe abdominal pain), and seek medical attention if these occur.
Comprehensive Drug Guide
How Does Olumiant Work?
Olumiant works by selectively inhibiting the activity of JAK1 and JAK2 enzymes. These enzymes play a crucial role in the signaling pathways of various cytokines and growth factors that mediate inflammatory responses. By blocking these pathways, Olumiant reduces inflammation, joint pain, and damage associated with rheumatoid arthritis.
Common Dosages
- Tablets: 2 mg and 4 mg.
Typical Dosing
- Adults: The typical starting dose is 2 mg taken orally once daily. Depending on the patient's response and tolerability, the dose may be increased to 4 mg once daily.
Typical Dosing
FDA Approved Indications
- Moderate to severe rheumatoid arthritis in adults, particularly in those who have not responded adequately to other therapies.
Who Shouldn't Take Olumiant?
- Known hypersensitivity to baricitinib or any component of the formulation
- Active infections, including tuberculosis
- Severe hepatic impairment
Advice From The Pharmacist
- Take Olumiant as prescribed, and do not exceed the recommended dose.
- Inform your healthcare provider about any other medications you are taking to avoid potential interactions.
- Monitor for signs of infection, such as fever or persistent cough, and report these to your healthcare provider.
- Regular blood tests may be required to monitor liver function, blood cell counts, and cholesterol levels during treatment.
Side Effects of Olumiant
Common Side Effects
- Nausea
- Headache
- Elevated liver enzymes
- Increased cholesterol levels
Uncommon/Severe Side Effects
- Serious infections (e.g., tuberculosis, bacterial infections)
- Blood clots (deep vein thrombosis, pulmonary embolism)
- Gastrointestinal perforations
Risks and Warnings of Olumiant
- Infection Risk: Olumiant may increase the risk of serious infections due to its immunosuppressive effects. Patients should be screened for tuberculosis before starting treatment.
- Blood Clots: Monitor for signs of blood clots, especially in patients with risk factors such as prolonged immobility or a history of thrombosis.
- Liver Function: Regular monitoring of liver enzymes is essential, as Olumiant can cause liver dysfunction.
Interactions with Olumiant
Common Drug Interactions
- Immunosuppressants: Caution is advised when combining with other immunosuppressive agents, as this can increase the risk of infections.
- Live Vaccines: Avoid live vaccines during treatment due to the potential for reduced immune response.
- Other Medications: Always inform your healthcare provider of all medications, including over-the-counter drugs and supplements, to avoid potential interactions.
Alternatives to Olumiant
- Other JAK Inhibitors: Such as tofacitinib for similar indications.
- Biologic DMARDs: Such as adalimumab or etanercept for rheumatoid arthritis management.
- Conventional DMARDs: Such as methotrexate for initial treatment options.
